Focused On LifeDeveloping novel therapies for serious diseases
Driven By ScienceRapid, efficient, cost-effective approach
Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families.
Medivation is proud to be a 2013 Top WorkplaceLearn More
April 3, 2014 Astellas Announces European Regulatory Submission For XTANDI® (enzalutamide) Capsules For Chemotherapy-Naive Metastatic Prostate Cancer Learn More